Market Overview

  • The Global Uveitis Market is estimated to reach a market value of USD XX million by 2025 from an initial market value of USD 2.89 billion in 2017. The uveitis market is expected to grow at a CAGR of XX% in the forecasted period 2018-2025.

 

What exactly is Uvetis?

  • Uveitis is an eye inflammation, which affects the middle layer of the tissue in the eyewall. The majority of the altered lie in population ages of 20 to 50 years. Uveitis can sometimes be a serious issue which can also lead to loss of vision.

 

Why is the global Uvetis Market growing at such a pace?

 

Global Uvetis Market is growing at the CAGR mentioned above due to a plethora of reasons. Among them, the significant ones are

  • Increasing incidents of eye disorders,
  • Increasing advancements in technologies leading to the development of new drugs, and
  • Growing product pipeline of pharma companies

 

What can be the reason for global Uvetis market not rising at the full potential?

  • High cost for the treatment, high risk of side effects are some of the major factors restraining the growth of the market.

 

What about the segmentation of the global Uvetis market and how are the regional markets performing?

  • The Uveitis market is segmented by clinical trial analysis, by treatment options, and by geography. By geography, North America dominated the market accounting for the largest share of the market.
  • By country, the United States, the United Kingdom, and Japan dominate the market. Emerging markets are witnessing a faster growth in the market with the market growing at a more rapid rate in those regions. The emergence of new companies in the developing nations is also encouraging the growth of the market.

 

Market Segmentation

The market is segmented into the following categories by given criteria

Treatment options:

  • Corticosteroids
  • Immunosuppressive Agents
  • Biologics
  • Adjuvant Therapy

 

How is the competitive landscape in the global Uvetis market?

 

Some of the major companies in the global Uvetis market include

  • Abbvie
  • Allergen
  • Bausch & Lamb
  • Alcon Pharmaceuticals

 

The global Uveitis market is relatively consolidated with top 4 companies accounting for the largest market share. There is a massive competition in the market with the presence of a large number of small and medium players.

 

Why should I purchase this report?

  1. To visualize the composition of the Uveitis market across each indication, regarding type and applications, highlighting the critical commercial assets and players.
  2. For the identification of commercial opportunities in Uveitis market by analyzing trends and co-development deals.
  3. Excel data sheet with thousands of data points of the Uveitis market – level 4/5 segmentation
  4. PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
  5. To get product mapping in excel for the critical Uveitis market products of all major market players

 

Is this the right report for me?

Yes, if you are one of these or related to one of these

  • Target Audience
  • Raw Material Suppliers/ Buyers
  • Product Suppliers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

 

1  Uveitis Market – Methodology and Scope

1.1 Research methodology
1.2 Scope of the Report

2. Uveitis Market  – Headlines & Trends

2.1 Headlines
2.2 Key Trends & Developments

3.Uveitis Market –  Industry Analysis

3.1 Market Drivers
3.2 Market Restraints
3.3 Porters Five Forces Analysis
3.3.1 Suppliers Power
3.3.2 Buyer Power
3.3.3 Industry Competition
3.3.4 Threat of new Entrant
3.3.5 Threat of Substitutes

4. Clinical Trial Analysis

4.1 By Age Group

4.1.1 Child
4.1.2 Adult
4.1.3 Senior
4.2 By Gender
4.2.1 Male
4.2.2 Female
4.3 By Study Phases
4.3.1 Early Phase
4.3.2 Phase 1
4.3.3 Phase 2
4.3.4 Phase 3
4.3.5 Phase 4
4.4 By Study Type
4.4.1 Interventional
4.4.2 Observational

5. Segmentation by Treatment Options

5.1 Corticosteroids
5.2 Immunosuppressive Agents
5.3 Biologics
5.4 Adjuvant Therapy

6. Geographic Analysis

6.1 North America
6.1.1 United States
6.1.2 Canada
6.1.3 Mexico
6.1.4 Others
6.2 Europe
6.2.1 United Kingdom
6.2.2 Spain
6.2.3 Germany
6.2.4 France
6.2.5 Rest of Europe
6.3 Asia-Pacific
6.3.1 India
6.3.2 China
6.3.3 Australia
6.3.4 Japan
6.3.5 Rest of Asia-Pacific
6.4 South America
6.4.1 Brazil
6.4.2 Argentina
6.4.3 Rest of South America
6.5 Rest of the World

7. Competitive Landscape

7.1 Market Share Analysis
7.2 Company Benchmarking
7.3 Key Strategies Adopted by Major Companies

8. Company Profiles*

8.1 AbbVie
8.2 Novartis
8.3 Pfizer
8.4 Bausch & Lomb
8.5 Allergan
8.6 Panacea Biotec
8.7 Merck
8.8 Regeneron Pharmaceuticals Inc.
8.9 pSivida Corp
8.10 Santen Pharmaceutical

9. Product Pipeline Analysis

10. Appendix
10.1 Sources
10.2 List of Charts
10.3 Expert Panel Validation
10.4 Disclaimer
10.5 Contact Us
*Note: Additional company profiles will be included on request.

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
step 1We collate your requirements.
step 2Our global research team is put into action.
step 3We deliver, and make sure your endeavour is a success!

Buy This Report